Cyclerion Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Revenue | $1,025 | $875 | $93 |
Gross Profit | 1,025 | 875 | 93 |
EBITDA | -838 | -976 | -1,672 |
EBIT | -1,672 | ||
Net Income | -799 | -976 | -324 |
Net Change In Cash | 1,025 | 875 | 93 |
Free Cash Flow | -1,579 | -264 | -503 |
Cash | 3,240 | 4,568 | 3,006 |
Basic Shares | 3,225 | 3,225 | 3,071 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,074 | $2,000 | $0 | $297 |
Gross Profit | 2,074 | 2,000 | -5,282 | |
EBITDA | -4,973 | -3,628 | -9,582 | -18,475 |
EBIT | -3,628 | -9,647 | -18,540 | |
Net Income | -3,528 | -3,057 | -5,263 | -44,078 |
Net Change In Cash | 2,074 | 2,000 | 0 | 297 |
Free Cash Flow | -3,314 | -4,333 | -21,245 | -40,611 |
Cash | 3,240 | 3,232 | 7,571 | 13,382 |
Basic Shares | 3,225 | 2,518 | 2,338 | 2,173 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.19 |
2025-09-30 | -$0.30 |
2025-06-30 | -$0.11 |
2025-03-31 | -$0.55 |